Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Reimportation Passes House; CBO Score May Keep It Out Of Medicare Rx

Executive Summary

The Congressional Budget Office's determination that prescription drug reimportation would not provide any cost savings could help House/Senate Medicare conferees distance themselves from the House's positive vote on reimportation

You may also be interested in...



New Senator Udall Favors Lower Drug Prices, But Not Through Importation

Mark Udall, D-Colo., moves to the Senate with a health care record in the House that includes a "no" vote in 2003 on the Medicare Part D prescription benefit program

New Senator Udall Favors Lower Drug Prices, But Not Through Importation

Mark Udall, D-Colo., moves to the Senate with a health care record in the House that includes a "no" vote in 2003 on the Medicare Part D prescription benefit program

Candidates For Corzine’s Senate Seat Include Reps. From Pharma Districts

Candidates to replace the open Senate seat to be vacated by Governor-elect Jon Corzine (D-N.J.) include congressmen with significant pharmaceutical manufacturer constituencies

Related Content

UsernamePublicRestriction

Register

PS042214

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel